Previous 10 | Next 10 |
Gainers: G Medical Innovations (NASDAQ:GMVD) +15%, Accuray (NASDAQ:ARAY) +14%, Xeris Biopharma (NASDAQ:XERS) +9%, DURECT (NASDAQ:DRRX) +9%, Ocugen (NASDAQ:OCGN) +7%. Losers: CareDx (NASDAQ:CDNA) -25%, 4D Molecular Therapeutics (NASDAQ:FDMT) -2...
DURECT Corporation to Announce Third Quarter 2021 Financial Results and Provide Business Update on November 2 PR Newswire CUPERTINO, Calif. , Oct. 26, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its third quarte...
DURECT Corporation Fireside Chat at the H.C. Wainwright 5th Annual NASH Investor Conference PR Newswire CUPERTINO, Calif. , Oct. 7, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James E. Brown , President and CEO, Mich...
DURECT Corporation Fireside Chat at the Cantor Fitzgerald Global Healthcare Conference 2021 PR Newswire CUPERTINO, Calif. , Sept. 23, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James E. Brown , President and CEO, Mic...
DURECT Corporation Fireside Chat at Oppenheimer's Fall Healthcare Life Sciences & MedTech Summit DURECT Corporation Fireside Chat at Oppenheimer's Fall Healthcare Life Sciences & MedTech Summit PR Newswire CUPERTINO, Calif. , Sept. 15, 2021 /PRNewswir...
DURECT Corporation Fireside Chat at the H.C. Wainwright Annual Global Investment Conference PR Newswire CUPERTINO, Calif. , Sept. 7, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that James E. Brown , President, CEO, Michael H. ...
DURECT Corporation (DRRX) Q2 2021 Results Conference Call July 29, 2021 04:30 PM ET Company Participants Mike Arenberg - CFO Jim Brown - President and CEO Norman Sussman - Chief Medical Officer Conference Call Participants Kristen Kluska - Cantor Fitzgerald Francois Brisebois - Oppenheimer Th...
DURECT Corporation Announces Second Quarter 2021 Financial Results and Update of Programs Earnings Call and Webcast Today, July 29th at 4:30 p.m. ET PR Newswire CUPERTINO, Calif. , July 29, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today anno...
DURECT Corporation to Announce Second Quarter 2021 Financial Results and Provide Business Update on July 29 PR Newswire CUPERTINO, Calif. , July 22, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its second quarter ...
Shares of DURECT Corporation (NASDAQ:DRRX) traded today at $1.30, breaking its 52-week low. This new low was reached on below average trading volume as 117,000 shares traded hands, while the average 30-day volume is approximately 609,000 shares. In the past 52 weeks, shares of DURECT Cor...
News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis PR Newswire DURECT plans to confirm the efficacy and safety of larsucosterol in a registrational Phase 3 clinical trial CUPERTINO, Calif. , May ...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 171.6% to $0.1657 on volume of 180,907,472 shares AMC Entertainment Holdings Inc. Class A (AMC) rose 84.4% to $9.57 on volume of 174,658,682 shares Plug Power Inc. (PLUG) rose 45.9%...
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update PR Newswire - FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Ea...